BCL2 and melanoma: To date, several transcription factors have been shown to control the activity of the BCL-2 promoter, for example, Aiolos in IL-2-deprived T cells [49], Mitf in the context of melanoma cell viability [50], and Pi in the context of B-cell differentiation [51].